105 k-feature signaturechip oligo solution ® whole-genome custom microarray Search Results


90
GenomeDx Inc microarray v3 105k oligo
Microarray V3 105k Oligo, supplied by GenomeDx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/105+k-feature+signaturechip+oligo+solution+%C2%AE+whole-genome+custom+microarray/microarray+v3+105k+oligo/pm22847950-280-69-73
Average 90 stars, based on 1 article reviews
microarray v3 105k oligo - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Oxford Gene Technology 180k-feature whole-genome microarray cytosure iscav2
180k Feature Whole Genome Microarray Cytosure Iscav2, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/105+k-feature+signaturechip+oligo+solution+%C2%AE+whole-genome+custom+microarray/180k+feature+whole+genome+microarray+cytosure+iscav2/pmc04613477-44-43-49
Average 90 stars, based on 1 article reviews
180k-feature whole-genome microarray cytosure iscav2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Signature Genomic Laboratories LLC 135k feature whole-genome microarray signaturechip® oligo solutiontm version 2.0
<t>Microarray</t> characterization of a complex rearrangement of chromosome 21. Microarray plot showing (1) a two-copy gain of 25 oligonucleotide probes from the long arm of chromosome 21 at 21q11.2, ˜220 kb in size; immediately followed by (2) a single-copy gain of 285 oligonucleotide probes from 21q11.2-21q21.1, ˜2.74 Mb in size; immediately followed by (3) a two-copy gain of 85 oligonucleotide probes from 21q21.1, ˜860 kb in size. Also present are (4) a single-copy gain of 107 oligonucleotide probes from 21q21.1, ˜1.35 Mb in size; (5) a single-copy loss of 153 oligonucleotide probes from 21q21.3q-21q22.11, ˜3.77 Mb in size; (6) a single-copy gain of 483 oligonucleotide probes from 21q22.12.-21q22.2, ˜5.21 Mb in size; and (7) a single-copy gain of 528 oligonucleotide probes from terminal 21q22.2-21q22.3, ˜5.89 Mb in size. Probes are ordered on the x -axis according to physical mapping positions, with the most proximal q-arm probes to the left and the most distal q-arm probes to the right. Values along the y -axis represent log2 ratios of patient:control signal intensities. Results are visualized using Genoglyphix® (Signature Genomics, Spokane WA).
135k Feature Whole Genome Microarray Signaturechip® Oligo Solutiontm Version 2.0, supplied by Signature Genomic Laboratories LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/105+k-feature+signaturechip+oligo+solution+%C2%AE+whole-genome+custom+microarray/135k+feature+whole+genome+microarray+signaturechip++oligo+solutiontm+version+2+0/pmc04184748-30-11-23
Average 90 stars, based on 1 article reviews
135k feature whole-genome microarray signaturechip® oligo solutiontm version 2.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Microarray characterization of a complex rearrangement of chromosome 21. Microarray plot showing (1) a two-copy gain of 25 oligonucleotide probes from the long arm of chromosome 21 at 21q11.2, ˜220 kb in size; immediately followed by (2) a single-copy gain of 285 oligonucleotide probes from 21q11.2-21q21.1, ˜2.74 Mb in size; immediately followed by (3) a two-copy gain of 85 oligonucleotide probes from 21q21.1, ˜860 kb in size. Also present are (4) a single-copy gain of 107 oligonucleotide probes from 21q21.1, ˜1.35 Mb in size; (5) a single-copy loss of 153 oligonucleotide probes from 21q21.3q-21q22.11, ˜3.77 Mb in size; (6) a single-copy gain of 483 oligonucleotide probes from 21q22.12.-21q22.2, ˜5.21 Mb in size; and (7) a single-copy gain of 528 oligonucleotide probes from terminal 21q22.2-21q22.3, ˜5.89 Mb in size. Probes are ordered on the x -axis according to physical mapping positions, with the most proximal q-arm probes to the left and the most distal q-arm probes to the right. Values along the y -axis represent log2 ratios of patient:control signal intensities. Results are visualized using Genoglyphix® (Signature Genomics, Spokane WA).

Journal: Clinical Case Reports

Article Title: Prenatal diagnosis of complex rearrangement of chromosome 21: The significance of interphase and metaphase fluorescence in situ hybridization and comparative genomic hybridization

doi: 10.1002/ccr3.22

Figure Lengend Snippet: Microarray characterization of a complex rearrangement of chromosome 21. Microarray plot showing (1) a two-copy gain of 25 oligonucleotide probes from the long arm of chromosome 21 at 21q11.2, ˜220 kb in size; immediately followed by (2) a single-copy gain of 285 oligonucleotide probes from 21q11.2-21q21.1, ˜2.74 Mb in size; immediately followed by (3) a two-copy gain of 85 oligonucleotide probes from 21q21.1, ˜860 kb in size. Also present are (4) a single-copy gain of 107 oligonucleotide probes from 21q21.1, ˜1.35 Mb in size; (5) a single-copy loss of 153 oligonucleotide probes from 21q21.3q-21q22.11, ˜3.77 Mb in size; (6) a single-copy gain of 483 oligonucleotide probes from 21q22.12.-21q22.2, ˜5.21 Mb in size; and (7) a single-copy gain of 528 oligonucleotide probes from terminal 21q22.2-21q22.3, ˜5.89 Mb in size. Probes are ordered on the x -axis according to physical mapping positions, with the most proximal q-arm probes to the left and the most distal q-arm probes to the right. Values along the y -axis represent log2 ratios of patient:control signal intensities. Results are visualized using Genoglyphix® (Signature Genomics, Spokane WA).

Article Snippet: The analysis of aCGH of the umbilical cord specimen, using a 135K feature whole-genome microarray (SignatureChip® Oligo SolutionTM version 2.0, custom designed by Signature Genomic Laboratories, LLC, made by Roche NimbleGen®, Madison, WI) identified a complex rearrangement of 21q; six gains including DSCR and one loss, resulting in both partial trisomy 21q and partial monosomy 21q (Fig. ).

Techniques: Microarray, Control